Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

guaifenesin dinitrate

Known as: MyoNovin 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

GuaifenesinNitrates
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Pharmaceutical Characterization of MyoNovin, a Novel Skeletal Muscle Regenerator: in silico, in vitro and in vivo Studies.
PURPOSE MyoNovin is a novel skeletal muscle-regenerating compound developed through synthesis of two nitro groups onto a… Expand
  • figure 1
  • table 1
  • table 2
  • figure 4
  • figure 5
2011
2011
Nitric oxide donors improve prednisone effects on muscular dystrophy in the mdx mouse diaphragm.
In Duchenne muscular dystrophy (DMD), palliative glucocorticoid therapy can produce myopathy or calcification. Since increased… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
2009
2009
Development of a nitric oxide-releasing analogue of the muscle relaxant guaifenesin for skeletal muscle satellite cell myogenesis.
Nitric oxide (NO) mediates activation of satellite precursor cells to enter the cell cycle. This provides new precursor cells for… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE